These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7805145

  • 1. [Investigation of EB virus DNA BamHI W fragment, EBNA-2 types and EBNA expression in benign and malignant nasopharyngeal biopsies].
    Chen XY, Ning S, Arrand JR.
    Zhonghua Bing Li Xue Za Zhi; 1994 Aug; 23(4):200-3. PubMed ID: 7805145
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The expression of HLA, Epstein-Barr virus nuclear antigen and the infiltration of T lymphocyte subsets in nasopharyngeal biopsy tissues].
    Chen X, Cai Y, Sun N.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994 Aug; 29(1):6-9. PubMed ID: 8031607
    [Abstract] [Full Text] [Related]

  • 4. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
    You S, Yao K, Cao Y.
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):23-6. PubMed ID: 8732106
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB.
    J Gen Virol; 1988 May; 69 ( Pt 5)():1051-65. PubMed ID: 2836550
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
    Fåhraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P.
    Int J Cancer; 1988 Sep 15; 42(3):329-38. PubMed ID: 2843473
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.
    Hu LF, Minarovits J, Cao SL, Contreras-Salazar B, Rymo L, Falk K, Klein G, Ernberg I.
    J Virol; 1991 Mar 15; 65(3):1558-67. PubMed ID: 1847471
    [Abstract] [Full Text] [Related]

  • 10. V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma.
    Zhang XS, Wang HH, Hu LF, Li A, Zhang RH, Mai HQ, Xia JC, Chen LZ, Zeng YX.
    Cancer Lett; 2004 Jul 28; 211(1):11-8. PubMed ID: 15194212
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Quantitative and localized detection of Epstein-Barr virus infectious status in nasopharyngeal carcinoma tissue].
    Jiang WH, Zhao SP, Yin ZH, Li F, Chen ZH, Xiao JY.
    Ai Zheng; 2005 Jul 28; 24(7):796-800. PubMed ID: 16004803
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.
    Tsai ST, Jin YT, Mann RB, Ambinder RF.
    Cancer; 1998 Apr 15; 82(8):1449-53. PubMed ID: 9554519
    [Abstract] [Full Text] [Related]

  • 14. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
    Wu SJ, Lay JD, Chen CL, Chen JY, Liu MY, Su IJ.
    J Med Virol; 1996 Dec 15; 50(4):314-21. PubMed ID: 8950688
    [Abstract] [Full Text] [Related]

  • 15. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP.
    Oral Oncol; 2008 Aug 15; 44(8):784-92. PubMed ID: 18206420
    [Abstract] [Full Text] [Related]

  • 16. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G.
    J Gen Virol; 1989 Nov 15; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [Abstract] [Full Text] [Related]

  • 17. Association of Epstein-Barr virus with nasopharyngeal carcinoma in Alaskan native patients: serum antibodies and tissue EBNA and DNA.
    Lanier AP, Bornkamm GW, Henle W, Henle G, Bender TR, Talbot ML, Dohan PH.
    Int J Cancer; 1981 Sep 15; 28(3):301-5. PubMed ID: 6274814
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus DNA in nasopharyngeal carcinoma in Thai patients at Ramathibodi Hospital, Bangkok.
    Niemhom S, Maeda S, Raksakait K, Petchclai B.
    Southeast Asian J Trop Med Public Health; 1995 Sep 15; 26 Suppl 1():325-8. PubMed ID: 8629135
    [Abstract] [Full Text] [Related]

  • 19. Serum EBV DNA as a biomarker in primary nasopharyngeal carcinoma of Indian origin.
    Krishna SM, James S, Kattoor J, Balaram P.
    Jpn J Clin Oncol; 2004 Jun 15; 34(6):307-11. PubMed ID: 15333681
    [Abstract] [Full Text] [Related]

  • 20. Detection of Epstein-Barr virus DNA and HHV-6 DNA in tissue biopsies from patients with nasopharyngeal carcinoma by polymerase chain reaction.
    Kositanont U, Kondo K, Chongkolwatana C, Metheetrairut C, Puthavathana P, Chantarakul N, Wasi C, Yamanishi K.
    Southeast Asian J Trop Med Public Health; 1993 Sep 15; 24(3):455-60. PubMed ID: 8160052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.